← Evidence map

ReviewOncoTargets and therapy2021

Targeted Treatment of Chronic Lymphocytic Leukemia: Clinical Utility of Acalabrutinib.

Candida Vitale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 35002256